145 related articles for article (PubMed ID: 6426197)
1. Effects of a glycopolypeptide from the slime of P. aeruginosa on phagocytosis by mouse macrophages.
Nadaud M
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Jul; 254(4):489-99. PubMed ID: 6426197
[TBL] [Abstract][Full Text] [Related]
2. Phagocytosis and intracellular killing of Pseudomonas aeruginosa by peritoneal macrophages of mice.
Maresz-Babczyszyn J; Czarny A; Lagowska-Złotorzycka M
Arch Immunol Ther Exp (Warsz); 1984; 32(4):481-7. PubMed ID: 6442853
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of a traditional Chinese medicine, xiao-chai-hu-tang (Japanese name: shosaiko-to), on Pseudomonas aeruginosa infection in mice.
Kawakita T; Yamada A; Mitsuyama M; Kumazawa Y; Nomoto K
Immunopharmacol Immunotoxicol; 1987; 9(4):523-40. PubMed ID: 3437105
[TBL] [Abstract][Full Text] [Related]
4. Protective activity of immune sera against extracellular slime from Pseudomonas aeruginosa on experimental infection in mice.
Sokalska M; Maresz-Babczyszyn J
Arch Immunol Ther Exp (Warsz); 1981; 29(5):643-52. PubMed ID: 6812542
[TBL] [Abstract][Full Text] [Related]
5. Modulation of macrophage function for defence of the lung against Pseudomonas aeruginosa.
Speert DP; Wong SY; Macdonald M; Sargeant R
Behring Inst Mitt; 1997 Feb; (98):274-82. PubMed ID: 9382751
[TBL] [Abstract][Full Text] [Related]
6. Nonopsonic phagocytosis and intracellular killing of Salmonella typhimurium by peritoneal macrophages of mice immunized with slime-extract from Pseudomonas aeruginosa.
Maresz-Babczyszyn J; Czarny A; Lagowska-Złotorzycka M
Arch Immunol Ther Exp (Warsz); 1985; 33(4):515-21. PubMed ID: 3936455
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
[TBL] [Abstract][Full Text] [Related]
8. Effect of experimental Pseudomonas aeruginosa infection on the activity of mouse phagocytes.
Izdebska-Szymona K; Nowakowska K; Sitnicka E
Arch Immunol Ther Exp (Warsz); 1983; 31(4):511-5. PubMed ID: 6670920
[TBL] [Abstract][Full Text] [Related]
9. A new scheme for additional typing of P. aeruginosa using antisera prepared against glycopolypeptide derived from the slime of the microorganisms.
Nadaud M
Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Aug; 260(1):71-80. PubMed ID: 2414949
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of bacterial binding to mouse macrophages by Pseudomonas alginate.
Oliver AM; Weir DM
J Clin Lab Immunol; 1983 Apr; 10(4):221-4. PubMed ID: 6408261
[TBL] [Abstract][Full Text] [Related]
11. Mouse-protection experience with monovalent Pseudomonas aeruginosa vaccine.
Sourek J; Výmola F; Zelenková L
Zentralbl Bakteriol A; 1980 Mar; 246(3):353-62. PubMed ID: 6775443
[TBL] [Abstract][Full Text] [Related]
12. Serologic and protective cross-reactivity of antisera to Pseudomonas aeruginosa extracellular slime glycolipoprotein.
Yushkova NA; Kholodkova EV; Korobova TS; Stanislavsky ES
Acta Microbiol Hung; 1986; 33(2):147-56. PubMed ID: 3101393
[TBL] [Abstract][Full Text] [Related]
13. Nonopsonic phagocytosis of Pseudomonas aeruginosa requires facilitated transport of D-glucose by macrophages.
Barghouthi S; Everett KD; Speert DP
J Immunol; 1995 Apr; 154(7):3420-8. PubMed ID: 7897223
[TBL] [Abstract][Full Text] [Related]
14. Development of an anti-adhesive vaccine for Pseudomonas aeruginosa targeting the C-terminal region of the pilin structural protein.
Sheth HB; Glasier LM; Ellert NW; Cachia P; Kohn W; Lee KK; Paranchych W; Hodges RS; Irvin RT
Biomed Pept Proteins Nucleic Acids; 1995; 1(3):141-8. PubMed ID: 9346845
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of human gamma-globulin preparation in experimental pseudomonas aeruginosa infections in mice and its mode of action.
Kamimura T
Arzneimittelforschung; 1984; 34(11):1528-34. PubMed ID: 6084512
[TBL] [Abstract][Full Text] [Related]
16. Studies on phagocytosis of mucoid and nonmucoid variants of Pseudomonas aeruginosa. II. Induction of heterologous immunity by mucoid strains of P. aeruginosa.
Gościniak G; Grzybek-Hryncewicz K
Arch Immunol Ther Exp (Warsz); 1988; 36(2):185-93. PubMed ID: 3149177
[TBL] [Abstract][Full Text] [Related]
17. Intratracheal immunization with pili protein protects against mortality associated with Pseudomonas aeruginosa pneumonia in mice.
Ohama M; Hiramatsu K; Miyajima Y; Kishi K; Nasu M; Kadota J
FEMS Immunol Med Microbiol; 2006 Jun; 47(1):107-15. PubMed ID: 16706793
[TBL] [Abstract][Full Text] [Related]
18. Multi-valent human monoclonal antibody preparation against Pseudomonas aeruginosa derived from transgenic mice containing human immunoglobulin loci is protective against fatal pseudomonas sepsis caused by multiple serotypes.
Lai Z; Kimmel R; Petersen S; Thomas S; Pier G; Bezabeh B; Luo R; Schreiber JR
Vaccine; 2005 May; 23(25):3264-71. PubMed ID: 15837231
[TBL] [Abstract][Full Text] [Related]
19. Outer membrane proteins of Pseudomonas aeruginosa as vaccine candidates.
von Specht BU; Domdey H; Schödel F; Blum B; Lücking C; Knapp B; Muth G; Hungerer KD; Bröker M
Behring Inst Mitt; 1994 Dec; (95):85-96. PubMed ID: 7538752
[TBL] [Abstract][Full Text] [Related]
20. The effect of antipolymorphonuclear leucocyte serum on Pseudomonas aeruginosa infection in rabbits.
Bullen JJ; Wallis SN; Griffiths E
Immunology; 1976 May; 30(5):603-10. PubMed ID: 819359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
